Translate to...

Avra Laboratories gets CDSCO nod to make Favipiravir API

Avra Laboratories gets CDSCO nod to make Favipiravir API
The company, in a press release, said it has developed an alternative low cost and highly efficient manufacturing process and is now supplying commercial quantities to drug maker Cipla for the launch of Ciplenza, the generic version of Favipiravir.